Abstract
Comparison of aortic arch repair using the endovascular technique, total arch replacement and staged surgery † 
INTRODUCTION
With the recent development of surgical techniques and managements, the conventional total arch replacement (TAR) method has become the standard surgical option for aortic arch aneurysms. The thoracic endovascular aortic repair (TEVAR) is widely recognized as an alternative option for thoracic aortic aneurysms, especially for high-risk patients. By combining TAR with an elephant trunk or arch vessel debranching or by improving devices, TEVAR can be extended to aortic arch pathologies [1, 2] . In this study, we used TEVAR including supra-aortic vessel debranching or fenestrated graft in patients who had a high risk for conventional TAR. We used staged thoracic endovascular repair (STEVAR) with TAR as the first stage and TEVAR as the second stage in patients with extended aortic arch pathology. The aim of this study was to evaluate the short-term and long-term outcomes of these approaches in a single centre.
METHODS
Between January 2001 and March 2016, 436 consecutive patients underwent aortic arch repair at our centre. Of these, 276 patients underwent conventional TAR, and 118 patients underwent TEVAR. The remaining 42 patients underwent STEVAR. The exclusion criteria included acute aortic dissection and hemi-arch or partial arch repair. The patient characteristics of three groups are listed in Table 1 . We performed open surgery as the first choice, particularly inpatients with shaggy aortic syndrome, Marfan syndrome, or aortic dissection. TEVAR is essentially indicated for elderly high-risk patients or those with comorbidity including severe frailty. The mean ages were 67.8 ± 10.1 years in the TAR group, 74.7 ± 10.4 years in the TEVAR group and 72.4 ± 8.3 years in the STEVAR group (P < 0.001). It was found that 36.4% patients in the TEVAR group, 5.4% patients in TAR group and 11.9% patients in STEVAR group were octogenarian (age > 80) (P < 0.001). The Japan SCORE (30 days operative mortality) was higher in the TEVAR group than in TAR or STEVAR groups (9.5 ± 8.6, 6.3 ± 5.1 and 5.5 ± 3.3, respectively; P < 0.001).
OPERATIVE TECHNIQUES
The procedural details of the three groups are given in Table 2 .
Open arch repair (TAR)
All patients underwent a median sternotomy. A left thoracotomy was added for 27 patients in whom the aneurysms extended further distally. The patients were cooled until the rectal or bladder temperature reached between 25 and 28 C. Three supra-aortic vessels were cannulated from their openings inside the incised aortic arch with balloon-tipped cannulas for selective cerebral perfusion (SCP). The initial total perfusion rate in supra-aortic vessels was regulated to maintain at 10 ml kg -1 min -1
. The target pressure measured at the tip of the left carotid cannula was 30 to 50 mmHg. The supra-aortic vessels were reconstructed using only a polyethylene terephthalate fiber (Dacron) graft with three branches for reconstruction. Most patients underwent open distal anastomosis, and the stepwise technique was applied for deep anastomoses.
Thoracic endovascular repair (TEVAR)
The details of our surgical technique of TEVAR with aortic arch vessel debranching have been previously reported [3] . Initially, we used the handmade stent graft devices, but then we used the commercially available TEVAR devices after their introduction in Japan in 2008. For spinal cord protection, we adopted cerebrospinal fluid drainage and motor evoked potential, particularly for patients with > _20 cm of aortic coverage or previous abdominal aortic surgery.
Zone 0
In the early phase of our series, total debranching with TEVAR was performed in patients with proximal zone 0 landing. To avoid median sternotomy and clamping of the ascending aorta, the surgical strategy was changed to the chimney technique or a fenestrated graft was used.
Zone 1
After bilateral axillary arteries and left common carotid artery (LCCA) bypass, a stent-graft was deployed through the femoral artery and positioned such that the proximal end of the covered stent-graft was in the aortic arch between the brachiocephalic artery and left common carotid artery (LCCA).
Zone 2
After the creation of the bilateral axillary arteries bypass, a stentgraft was deployed through the femoral artery and positioned such that the proximal end of the covered stent-graft was in the aortic arch between left common carotid artery (LCCA) and left subclavian artery (LSA).
Staged thoracic endovascular repair (STEVAR)
The first stage involving the elephant trunk technique was performed similarly to the above-described standard TAR. Distal anastomosis was performed at the proximal side of the aneurysm. The length of the elephant trunk was between 5 and 7 cm. For patients with very large aneurysms, we performed a second-stage operation during the same hospitalization period. However, most patients were discharged after the first stage, and they underwent the second stage of STEVAR at a later period. The median duration between the two operations was 2 months [interquartile range (IQR: 1-3)]. In the second stage, a stent graft main body was deployed inside the elephant trunk. In STEVAR group, the first stage operation had shorter operation time (370 ± 123 vs 452 ± 147 min; P = 0.002), cardiopulmonary bypass (CPB) time (186 ± 41 vs 225 ± 65 min; P < _ 0.001), aortic crossclamp time (119 ± 28 vs 145 ± 42; P < 0.001) and SCP time (86 ± 16 vs 101 ± 28; P < 0.001).
Definition of outcomes
Mortality was reported as 30-day mortality, and hospital death was defined as any death prior to hospital discharge. Late mortality is defined as all-cause mortality, and the time origin is the time of surgery. In the STEVAR group, the time origin is first stage operation. Permanent neurologic deficit is defined as a new neurological deficit persistent at the time of discharge, and temporary neurologic deficit is defined as a new neurological deficit with complete resolution by discharge. Aortic reintervention was defined as reintervention for the previously repaired arch segment.
Endpoints and follow-up
Primary end-points were hospital morality and late mortality.
Data were recorded prospectively. The patients were followed by the outpatient unit of our institution. In the case of patient follow-ups in other hospitals, telephonic conversations were conducted. The final date of follow-up was March 2016, and the mean duration of the follow-up was 48.3 ± 3.3 months, and it was completed for 91% of our cohort.
Statistical analysis
Continuous data were expressed as means ± standard deviation or median with interquartile range. Among the three groups, continuous data were compared by one-way analysis of variance (ANOVA), and categorical data were compared by the v 2 test. Risk factors for in-hospital mortality was evaluated using logistic regression analysis. Clinically relevant variables with P < 0.25 in univariable analysis were included in multivariable regression analyses as candidates for backward stepwise variable selections. Cox proportional hazards regression was performed to estimate the hazard ratio (HR) for risk factors on late mortality and aortic reintervention. Survival and aortic reintervention free rates were estimated using the Kaplan-Meier method and were compared among groups using log-rank test. In addition, sensitivity analyses by means of propensity score matching (PSM) were performed. By PSM, the number of STEVAR group was too small compared to the other two groups. Since STEVAR involved TAR followed by TEVAR, TEVAR was compared with open surgery, which included TAR and STEVAR. The PSM was estimated using a logistic regression model (eight factors and covariates: age, gender, octogenarian, rupture, prior sternotomy, aortic pathologies and extend of aneurysm) and greedy matching (ratio = 1:1 without replacement) with a calliper of width 0.25 standard deviations of the logit of the estimated PS was applied. After the matching, survival curves were compared between the two groups with log rank test. All data were analysed using SPSS 22.0 software (IBM Corp., Armonk, NY, USA).
RESULTS
The perioperative outcomes are listed in Table 3 . The overall hospital mortality was 3.9% (17/436), including 5.1, 2.5 and 0% in the TAR, TEVAR and STEVAR groups, respectively (P = 0.192). The cause of death in all cases was as follows: pulmonary-related in 10 patients, stroke in 2, multiple organ failure in 1, low output syndrome in 1, hepatic failure in 1, arrhythmia in 1 and residual thoracoabdominal aortic aneurysm rupture in 1 patient. Neurologic dysfunction developed in 15 (5.4%) patients in the TAR group, in 10 (8.5%) patients in TEVAR group and in 1 (2.4%) patient in the STEVAR group (P = 0.297). Spinal cord injury (SCI) developed in 1 patient each in TAR (0.4%) and TEVAR (0.8%) groups; however, there were no such deficits in the STEVAR group (P = 0.726). Prolonged intubation for longer than 48 h was required for 74 (28.1%) patients in the TAR group, 6 (5.3%) patients in TEVAR group and 2 (5.4%) patients in STEVAR group (P < 0.001). The ICU length of stay (P < 0.001) and the duration of postoperative hospital stay (P = 0.001) were significantly shorter in the TEVAR group. Figure 1A shows the overall long-term survival assessed by the Kaplan-Meier method. Survival at 3 and 5 years after surgery was 84.0 ± 2.3 and 78.3 ± 2.8% in the TAR group, 79.1 ± 4.0 and 72.4 ± 5.2% in TEVAR group and 93.8 ± 4.3 and 79.0 ± 8.8% in STEVAR group, respectively. There was no significant difference between the three groups (P = 0.123). Late deaths occurred in 84 patients (19.3%). Of these, 17 (20.2%) were aorta-related deaths, including rupture of a descending thoracic or thoraco-abdominal aneurysm in 9 cases, an aortic arch aneurysm in 1, brachiocephalic aneurysm in 2, aortic dissection in 1 and sudden death in 4 patients. Cardiac-related deaths occurred in 8 patients (9.5%), including congestive heart failure in 6 and acute myocardial infarction in 2 patients. Other deaths occurred as follows: respiratory failure in 14 patients (16.7%), cancer in 13 (15.5%), cerebral accident in 7 (8.3%), sepsis in 5 (6.0%), gastrointestinal complications in 3 (3.6%), renal failure in 1 (1.2%) and unknown in 16 patients (19.0%). Multivariable analysis demonstrated that the risk factors for mortality after surgery were octogenarian (HR, 2.49; P < 0.001), prior cerebral infarction (HR, 1.86; P = 0.014) and rupture (HR, 2.07; P = 0.032) ( Table 5 ).
Late aortic reintervention occurred in 12 (2.8%) patients, including 5 in the TAR group, 6 in TEVAR group and 1 in STEVAR group. Figure 2A shows freedom from reintervention at 3 and 5 years after surgery was 99.5 ± 0.5 and 97.8 ± 1.3% in the TAR group, 95.2 ± 2.1 and 91.9 ± 3.8% in TEVAR group and 97.1 ± 2.8 and 97.1 ± 2.8% in STEVAR group (P = 0.040). In the TAR group, re-open surgery was performed in 2 patients due to pseudoaneurysm of the anastomotic site and in 2 patients due to graft infection. TEVAR was performed in 1 patient due to distal anastomotic pseudoaneurysm. In the TEVAR group, reoperations were performed in 4 patients due to endoleak and in 2 patients due to retrograde aortic dissection. In the STEVAR group, only 1 patient required open descending aortic replacement for aortobronchial fistula due to endoleak. Univariable analysis demonstrated that TEVAR exhibited a tendency towards higher aortic reintervention, but the difference was not statistically significant (Table 6 ).
According to the propensity matching analysis, ICU stay and postoperative hospital stay were shorter in the TEVAR group than in OPEN (TAR and STEVAR) group (P < 0.001 and P < 0.001, respectively). The survival rates in the OPEN and TEVAR groups were 66.6 ± 6.4 and 74.6 ± 6.4% at 5 years, respectively (P = 0.465) (Fig. 1B) . The freedom from reintervention in the OPEN group and TEVAR group were 100% and 91.0 ± 5.1% at 5 years, respectively (P = 0.031) (Fig. 2B) .
DISCUSSION
In the present study, the in-hospital mortality was 3.9% for all patients, including 5.1% of TAR group, 2.1% of TEVAR group and 0% of STEVAR group. Contemporary studies [4] [5] [6] [7] [8] [9] [10] [11] have reported an early mortality rate of 4 to 10% in aortic arch operation with SCP and 2 to 6% in hybrid procedures with a stent graft [12] [13] [14] . Our early outcomes after the aortic arch operation can be compared favourably with those of the previous reports. In our study, the risk factors for hospital mortality were perioperative neurologic dysfunction and rupture at admission. Octogenarian is not a surgical risk factor in our study. We recommend TAR even for octogenarians without severe frailty. The neurologic dysfunction rates were 5.4% in the TAR group and 2.1% in STEVAR group, and these values are comparable with the results of others [6, 7] . We used moderate hypothermic circulatory arrest with antegrade SCP. Okita et al. [15] described that antegrade SCP might be preferred for brain protection in the cases of complicated aortic arch procedures. In the TEVAR group, the neurologic dysfunction rate was 8.5%, which is a matter of concern. At the beginning of our series, most of the strokes occurred in vertebral/basilar lesions. We, therefore, introduced left subclavian artery occlusion before deploying the stent graft main body, resulting in decreased stroke rate [16] . The management of extensive aortic aneurysm is still a challenge [17] . In TAR, distal anastomosis is a challenge if it is very deep from the median sternotomy and the aneurysm is large. However, in the STEVAR, distal anastomosis is proximal to the aneurysm and an ostium of left subclavian artery, and is easier and less invasive than the conventional TAR. It may result in shorter cardiopulmonary bypass (CPB) time, SCP time and operation time than the TAR group in our study. However, there is the risk of rupture between the two stages. In our study, 1 patient died after the first-stage operation while waiting for the next operation. The frozen elephant trunk technique allows single-stage repair of extensive aortic arch disease [18, 19] . However, it needs to be accepted that the risk of SCI is as low as that of conventional TAR. We performed FET technique only on patients whose aneurysm can be treated by the short length of the stent graft or with small access for stent graft delivery. This point led to the low rate of SCI, i.e. 0.4% in TAR group and 0% in STEVAR group.
Aortic reintervention free rate was lower in the TEVAR group than in other groups, and there was no significant difference between the groups in terms of long-term survival. In our report, the superiority of debranching with TEVAR compared with total arch or STEVAR was not evident except for shorter ICU length of stay and postoperative hospital stay and lesser long intubation time. Cao et al. [20] concluded that there are no reliable longterm data to ascertain the durability of hybrid arch repair (HAR). Our own results presented herein reflected similar findings. HAR procedures have been proposed as a means to circumvent perioperative morbidity and mortality associated with conventional TAR in high-risk patients [20, 21] . The results of the current study suggest that HAR is generally safe and effective for patients believed to be inappropriate for conventional open arch repair [22, 23] . However, regarding to native zone 0 landing, HAR is still controversial [24, 25] . There are a few new commercial devices for zone 0 landing [26] . Although these devices may be promising, they are yet to be approved for general use. Under these circumstances, open surgery remains the gold standard for aortic arch pathology.
Limitation
The study was a retrospective analysis. Other limitations of this study include the small sample size and smaller size of each cohort. Therefore, further investigations with a larger cohort and follow-ups are required.
CONCLUSIONS
Aortic arch aneurysm was repaired with acceptable mortality and morbidity in each type of operation. The postoperative outcomes of the three groups were similar, except that the TEVAR group had shorter ICU stay and hospital stay compared to the other two groups. There was no significant difference between the groups in terms of long-term survival. However, TEVAR had inferiority of freedom from aortic reintervention compared to TAR.
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